The New York Times

The son of Cindy Crawford, who died last month, left behind a trove of first-person testimonials about years of drug use, trying to stay clean and his mental health.

Ken Paxton, the Texas attorney general and Republican Senate candidate, has alleged a sprawling profit-driven conspiracy. Pediatricians say the accusations are an attempt at intimidation.

Karl Deisseroth, Peter Hegemann, Georg Nagel were awarded the prize for their work on light-gated ion channels and optogenetics.

By pinpointing when it begins in young humans, scientists hope to better understand what consciousness is, and how it arises, in all of us.

Cancer patients are being persuaded to spend tens of thousands on unproven treatments by alternative-medicine clinics.

Small particulates sent up by wildfires are a well-documented health hazard. But recent research finds that ground-level ozone is now on the rise, too.

Salata Dressings initiated the recall of its Jalapeño Avocado Dressing in August over concerns about possible salmonella contamination.

The discovery adds strong evidence that the outbreak that sickened thousands over the summer originated in the company’s fields or processing facility in northeastern Mexico.

Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.

A catheter carrying the lethal drug may not have delivered the doses to Christa Pike’s bloodstream, experts said. The drug itself may have been degraded.

Ketamine a short-acting anesthetic that can have hallucinogenic effects. It is becoming more easily available, and some experts fear misuse is increasing.

Erin Lee Carr’s new documentary revisits the 2004 makeover show “The Swan,” which gave 32 women extensive plastic surgery and anticipated where beauty culture was headed.

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Epic’s engineers deployed an Anthropic tool that exposed security risks that could allow undetected access to millions of patient records.

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.